Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Arnofsky

Thoracic Surgery (Cardiothoracic Vascular Surgery) Englewood, NJ Medical Doctor

NPI 1245301332 CMS profile 101389

350 Engle St, Englewood, NJ 07631

Open in the dashboard

General payments

$131,518

545 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$9,175 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Adam Arnofsky of Englewood, NJ is reported in the CMS Open Payments database as having received $131,518 across 545 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $9,175 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40,530 78
2024 General $24,630 117
2023 General $25,368 93
2022 General $26,657 80
2021 General $7,933 52
2020 General $1,549 41
2019 General $4,851 84

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Arnofsky
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Adam Arnofsky were reported at $40,530. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Adam Arnofsky Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,851 $886 $178–$3,167 $163
2020 $1,549 $341 $108–$1,605 $114
2021 $7,933 $453 $125–$1,886 $132
2022 $26,657 $695 $180–$2,566 $149
2023 $25,368 $745 $205–$2,662 $160
2024 $24,630 $799 $214–$2,967 $164
2025 $40,530 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $91,225 154 payments
  2. Abbott Laboratories $14,842 36 payments
  3. Edwards Lifesciences Corporation $10,187 141 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $8,304 18 payments
  5. Abiomed $2,674 82 payments
  6. Medtronic Vascular, Inc. $1,238 36 payments
  7. Atricure, Inc. $474 12 payments
  8. Boston Scientific Corporation $359 5 payments
  9. Davol Inc. $240 3 payments
  10. CVRx, Inc. $232 2 payments
  11. Other $1,745 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $92,345 41 payments
  2. Food and Beverage $20,415 473 payments
  3. Consulting Fee $12,000 4 payments
  4. Travel and Lodging $6,739 26 payments
  5. Entertainment $20 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $84,252 124 payments
  2. LifeVest $8,304 18 payments
  3. AMPLATZER AMULET $7,200 2 payments
  4. CoreValve Evolut $6,956 29 payments
  5. NAVITOR $5,335 11 payments
  6. Edwards SAPIEN 3 Transcatheter Heart Valve $2,977 27 payments
  7. Impella $2,306 67 payments
  8. MITRACLIP $1,641 10 payments
  9. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $1,369 29 payments
  10. PASCAL $1,295 8 payments
  11. Other $8,735 196 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$120,318

Medicare's payments for the services billed

Medicare patients

162

Average age 78

Services billed

333

65 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 69%
Diabetes 51%
Arthritis 51%
Atrial fibrillation 46%
Chronic kidney disease 44%
Cancer 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

545 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record